Publicacións en colaboración con investigadores/as de Universitat de Girona (32)

2024

  1. Practical tool to identify Spasticity-Plus Syndrome amongst patients with multiple sclerosis. Algorithm development based on a conjoint analysis

    Frontiers in Neurology , Vol. 15

2023

  1. Deciphering multiple sclerosis disability with deep learning attention maps on clinical MRI

    NeuroImage: Clinical, Vol. 38

  2. Global and Regional Deep Learning Models for Multiple Sclerosis Stratification From MRI

    Journal of Magnetic Resonance Imaging

  3. Liquid Chromatography Fingerprint Analysis of Released Compounds in Plasma Samples of Stroke Patients after Thrombolytic Treatment

    Separations, Vol. 10, Núm. 1

  4. Seroprevalence of SARS-CoV-2 in Patients with Multiple Sclerosis under Disease-Modifying Therapies: A Multi-Centre Study

    Journal of Clinical Medicine, Vol. 12, Núm. 23

2022

  1. Cav-1 Protein Levels in Serum and Infarcted Brain Correlate with Hemorrhagic Volume in a Mouse Model of Thromboembolic Stroke, Independently of rt-PA Administration

    Molecular Neurobiology, Vol. 59, Núm. 2, pp. 1320-1332

  2. Is humoral and cellular response to SARS-CoV-2 vaccine modified by DMT in patients with multiple sclerosis and other autoimmune diseases?

    Multiple Sclerosis Journal, Vol. 28, Núm. 7, pp. 1138-1145

2021

  1. Integrated Management of Multiple Sclerosis Spasticity and Associated Symptoms Using the Spasticity-Plus Syndrome Concept: Results of a Structured Specialists' Discussion Using the Workmat® Methodology

    Frontiers in Neurology, Vol. 12

2020

  1. Evaluation of long-term rt-PA effects on bEnd.3 endothelial cells under ischemic conditions; changes in ZO-1 expression and glycosylation of the bradykinin B2 receptor

    Thrombosis Research, Vol. 187, pp. 1-8

  2. Targeted resequencing reveals rare variants enrichment in multiple sclerosis susceptibility genes

    Human Mutation, Vol. 41, Núm. 7, pp. 1308-1320

2018

  1. 2,5-dimethylfuran as a validated biomarker of smoking status

    Nicotine and Tobacco Research, Vol. 21, Núm. 6, pp. 828-834

  2. Evaluation of common housekeeping proteins under ischemic conditions and/or rt-PA treatment in bEnd.3 cells

    Journal of Proteomics, Vol. 184, pp. 10-15

  3. Exome sequencing study in patients with multiple sclerosis reveals variants associated with disease course 06 Biological Sciences 0604 Genetics 11 Medical and Health Sciences 1109 Neurosciences

    Journal of Neuroinflammation, Vol. 15, Núm. 1

  4. Low levels of caveolin-1 predict symptomatic bleeding after thrombolytic therapy in patients with acute ischemic stroke

    Stroke, Vol. 49, Núm. 6, pp. 1525-1527

2017

  1. Diffusion tensor imaging as a prognostic biomarker for motor recovery and rehabilitation after stroke

    Neuroradiology, Vol. 59, Núm. 4, pp. 343-351

  2. High-permeability region size on perfusion CT predicts hemorrhagic transformation after intravenous thrombolysis in stroke

    PLoS ONE, Vol. 12, Núm. 11

2016

  1. Breath gas concentrations mirror exposure to sevoflurane and isopropyl alcohol in hospital environments in non-occupational conditions

    Journal of Breath Research, Vol. 10, Núm. 1

  2. Ethyl-bridged hybrid column as an efficient alternative for HPLC analysis of plasma amino acids by pre-column derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate

    Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 1029-1030, pp. 137-144

  3. mTOR: Exploring a New Potential Therapeutic Target for Stroke

    Molecules to Medicine with mTOR: Translating Critical Pathways into Novel Therapeutic Strategies (Elsevier Inc.), pp. 105-122

2014

  1. Sequential discriminant classification of environments with different levels of exposure to tobacco smoke

    Science of the Total Environment, Vol. 490, pp. 899-904